Onco-Day 2025: a resounding success at the Genolier Innovation Hub
On 31 October 2025, Swiss Medical Network's Onco-Day was held at the Genolier Innovation Hub, bringing together specialists in oncology, radiation oncology, nuclear medicine, surgical disciplines and pathology. The day featured a rich programme of lectures, interactive case discussions and scientific exchanges, offering a multidisciplinary overview of the current state and future prospects of cancer treatment.
Participants were able to explore topics such as theranostics, liquid biopsies, innovations in radiosurgery and the latest advances in breast cancer surgery. International speakers included:
- Prof. Dr. Anne-Laure Giraudet – Chief Medical Officer, Department of Radioligand Therapy, Léon Bérard Centre, Lyon
- Dr. Emanuela Ferraro – European Institute of Oncology, Milan, Italy
- Dr. Antoine Leimgruber – FMH Specialist in Nuclear Medicine, Clinique de Genolier, Genolier
- Prof. Dr. Holger Moch – Department of Pathology and Molecular Pathology, USZ, Zurich
- Prof. Dr. Lana E. Kandalaft – Development of the Clinical and Phase I Research Unit, Swiss Medical Network
- Thomas McKee – Director of Molecular Pathology, FMH Specialist in Pathology & Molecular Pathology, Aurigen Pathology Centre, Sonic Suisse
- Prof. Dr. Philip Poortmans – Radiation Oncologist, Iridium Network and University of Antwerp, Belgium
- Dr. Francesca Caparrotti – Specialist in Radiation Oncology, Clinique Générale Beaulieu, Geneva
- Prof. Dr. Constantin Tuleasca – Associate Professor of Neurosurgery, FMH Specialist in Neurosurgery, Clinique de Montchoisi, Lausanne
- Dr Maria Joao Cardoso – Head of the Breast Unit, Champalimaud Foundation Breast Unit, Lisbon; Associate Professor, University of Lisbon
- Prof. Dr Pietro Di Summa – FMH Specialist in Plastic, Reconstructive and Aesthetic Surgery, Clinique de Genolier, Genolier
- Prof. Dr Michael Gnant – Professor of Surgery, University of Vienna President of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
The interactive question-and-answer sessions and practical case studies were particularly appreciated, encouraging discussion among participants. Beyond its scientific excellence, the event provided an opportunity for high-quality networking, generating new ideas for clinical practice and research collaboration.
Onco-Day 2025 confirms the Swiss Medical Network's position as a centre of excellence for innovation, knowledge transfer and collaboration in multidisciplinary oncology.
